Uncategorized

 Points The Food and Drug Administration on Thursday said the active ingredient in Eli Lilly’s weight loss drug Zepbound is no longer in shortage, a decision that will eventually bar compounding pharmacies from making cheaper, unbranded versions of the injection. “FDA has determined that the shortage of tirzepatide injection products, which first began… Read More »FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage

Bitcoin’s rally to new heights signals even more momentum for a stock market that’s also at all-time highs, according to Fundstrat’s Tom Lee. “Bitcoin rising is, to me, breaking out of a holding pattern as a precursor to what the S&P 500 is going to do for the rest of the year,” Lee… Read More »Fundstrat’s Tom Lee thinks the bitcoin rally above $100,000 is a bullish signal for stocks